Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aged Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05075044
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

Who this might be right for
HIV InfectionsCOVID-19
China National Biotec Group Company Limited 400
Not applicableNot Yet RecruitingNCT07130201
What this trial is testing

Sleep and Automatic Dysfunction in Elderly Cardiovascular Patients

Who this might be right for
Cardiovascular Diseases
Assiut University 210
Not applicableWithdrawnNCT04772092
What this trial is testing

Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older

Who this might be right for
Geriatrics Immunosenescence
Centre Hospitalier Universitaire Dijon
Not applicableStudy completedNCT01329536
What this trial is testing

The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseAgitation
Avera McKennan Hospital & University Health Center 50
Not applicableLooking for participantsNCT05842928
What this trial is testing

Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy

Who this might be right for
DeprescriptionsAntidepressive AgentsAntipsychotic Agents+3 more
Ludwig-Maximilians - University of Munich 352
Post-approval studies (Phase 4)Study completedNCT00812864
What this trial is testing

Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)

Who this might be right for
Breast CancerColorectal Cancer
University Hospital, Limoges 20
Not applicableStudy completedNCT03974906
What this trial is testing

Goal-directed Fluid Therapy in Elderly Patients Undergoing Lumbar Surgery

Who this might be right for
Lactate Blood IncreaseFluid OverloadPostoperative Complications
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00602771
What this trial is testing

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Ended earlyNCT00120198
What this trial is testing

Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma
Geriatric Oncology Consortium 50
Not applicableStudy completedNCT03519139
What this trial is testing

Individual Nutritional Intervention for the Prevention of Readmission Among Geriatric Patients

Who this might be right for
Readmission
Jens Rikardt Andersen 40
Not applicableWithdrawnNCT04085081
What this trial is testing

Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers

Who this might be right for
CaregiverLobectomy PatientLung Carcinoid Tumor+1 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT01304771
What this trial is testing

Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly

Who this might be right for
Influenza
Mayo Clinic 22
Not applicableStudy completedNCT00450034
What this trial is testing

Optimization of Drug Treatment in Hospitalized Elderly (OMAGE)

Who this might be right for
Global Medical Assessment of Elderly Frail Patients
Assistance Publique - Hôpitaux de Paris 665
Not applicableActive Not RecruitingNCT03913299
What this trial is testing

Frailty Assessment by Edmonton Frail Scale to Predict Outcome in Patients Undergoing Cardiovascular Surgery

Who this might be right for
Frail Elderly SyndromeFrailtySurgery
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2,080
Testing effectiveness (Phase 2)Looking for participantsNCT06032052
What this trial is testing

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

Who this might be right for
Elderly PatientsMetastatic Lung Cancer
Hubei Cancer Hospital 49
Not applicableNot Yet RecruitingNCT06711328
What this trial is testing

Effect of New Oropharyngeal Airway on Incidence of Hypoxia During Painless Gastroenteroscopy in Elderly Patients

Who this might be right for
Airway ManagementElderly Patients
Jianbo Wu 164
Not applicableLooking for participantsNCT06652828
What this trial is testing

Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients

Who this might be right for
Fall PreventionExerciseGeriatrics+2 more
University of Oldenburg 396
Not applicableUnknownNCT05455892
What this trial is testing

Mortality, Gravity Predictive Factors and Clinical Evolution of Older COVID-19 Patients in Short Geriatric Services.

Who this might be right for
COVID-19
Hospices Civils de Lyon 450
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00963534
What this trial is testing

Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.

Who this might be right for
Mantle Cell Lymphoma
Lund University Hospital 51
Next Page